A PROTON PUMP INHIBITOR, E3810, HAS ANTIBACTERIAL ACTIVITY THROUGH BINDING TO HELICOBACTER-PYLORI

被引：40

作者：

HIRAI, M

AZUMA, T

ITO, S

KATO, T

KOHLI, Y

机构：

[1] Second Department of Internal Medicine, Fukui Medical School, Fukui, 910-11, Matsuoka-cho, Yoshida-gun

来源：

JOURNAL OF GASTROENTEROLOGY | 1995年 / 30卷 / 04期

关键词：

HELICOBACTER PYLORI; PROTON PUMP INHIBITOR; SCATCHARD PLOT ANALYSIS;

D O I：

10.1007/BF02347561

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Helicobacter pylori infection is causally related to atrophic gastritis, and it may also be associated with peptic ulcer and gastric carcinoma. Eradication of H. pylori is recommended in patients with such diseases, especially in those with peptic ulcer. A new potent proton pump inhibitor, E3810, had an antibacterial effect on H. pylori, as has been reported for omeprazole and lansoprazole, two other proton pump inhibitors. The minimum inhibitory concentration of E3810 was 1.57-3.13 mu g/ml, lower than that of omeprazole or lansoprazole. To clarify the mechanism of the antibacterial effect of E3810, we analyzed the characteristics of E3810 binding to H. pylori. Scatchard plot analysis of this binding showed a curvilinear profile, indicating the presence of several molecules with different affinities to E3810 on H. pylori. The binding capacity of E3810 to H. pylori was calculated to be about 2 x 10(6) sites/cell. These results suggested that E3810 has an antibacterial effect against H. pylori and that the effect may be mediated through direct binding to H. pylori.

引用

页码：461 / 464

页数：4

共 17 条

[11]

Labenz J., Ruhl G.H., Bertra J., Et al., Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease, Am J Gastroenterol, 89, pp. 726-730, (1994)

[12]

Van Zanten S.J.O., Goldie J., Hollingsworth J., Et al., Secretion of intravenously administered antibiotics in gastric juice: Implications for management of Helicobacter pylori, Journal of Clinical Pathology, 45, pp. 225-227, (1992)

[13]

Hunt R.H., pH and Hp-Gastric acid secretion and Helicobacter pylori: Implication for ulcer healing and eradication of the organism, Am J Gastroenterol, 88, pp. 481-483, (1993)

[14]

Mauch I., Bode G., Malfertheiner P., Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors, Am J Gastroenterol, 88, pp. 1801-1802, (1993)

[15]

Nagata K., Satoh H., Iwahi T., Et al., Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: Unique action selective for H. pylori cells, Antimicrob Agents Chemother, 37, pp. 769-774, (1993)

[16]

Segal E.D., Shon J., Tompkins L.S., Characterization of Helicobacter pylori urease mutants, Infect Immun, 60, pp. 1883-1889, (1992)

[17]

McGowan C.C., Cover T.L., Blaser M.J., The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism, Gastroenterology, 107, pp. 738-743, (1994)

← 1 2 →